EnBio Holdings, Inc (TYO:6092)
Japan
· Delayed Price · Currency is JPY 576.00
-2.00 (-0.35%)
Apr 25, 2025, 9:55 AM JST
EnBio Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 10,780 | 9,575 | 8,120 | 8,987 | 6,840 | 7,408 | Upgrade
|
| Revenue Growth (YoY) | 29.34% | 17.92% | -9.65% | 31.39% | -7.67% | -13.49% | Upgrade
|
| Cost of Revenue | 7,858 | 7,092 | 5,355 | 6,562 | 4,950 | 5,321 | Upgrade
|
| Gross Profit | 2,923 | 2,483 | 2,765 | 2,425 | 1,890 | 2,087 | Upgrade
|
| Selling, General & Admin | 1,740 | 1,668 | 1,407 | 1,196 | 1,165 | 1,262 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 107 | 151 | Upgrade
|
| Operating Expenses | 1,739 | 1,667 | 1,407 | 1,181 | 1,272 | 1,413 | Upgrade
|
| Operating Income | 1,183 | 816 | 1,358 | 1,244 | 618 | 674 | Upgrade
|
| Interest Expense | -130.7 | -114 | -124 | -123 | -125 | -130 | Upgrade
|
| Interest & Investment Income | 60.96 | 45 | 36 | 25 | 10 | 2 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -1 | Upgrade
|
| Currency Exchange Gain (Loss) | 197.69 | 186 | 65 | 80 | 17 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 128.22 | 133 | 8 | -30 | 73 | -24 | Upgrade
|
| EBT Excluding Unusual Items | 1,440 | 1,066 | 1,343 | 1,196 | 593 | 521 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -2 | 11 | 312 | Upgrade
|
| Asset Writedown | -10.33 | -12 | -110 | -95 | -116 | - | Upgrade
|
| Other Unusual Items | 10 | 10 | - | -1 | - | - | Upgrade
|
| Pretax Income | 1,389 | 1,064 | 1,233 | 1,098 | 488 | 833 | Upgrade
|
| Income Tax Expense | 468.76 | 326 | 437 | 392 | 157 | 301 | Upgrade
|
| Earnings From Continuing Operations | 920.1 | 738 | 796 | 706 | 331 | 532 | Upgrade
|
| Minority Interest in Earnings | 8.42 | -30 | 16 | -52 | -27 | 23 | Upgrade
|
| Net Income | 928.52 | 708 | 812 | 654 | 304 | 555 | Upgrade
|
| Net Income to Common | 928.52 | 708 | 812 | 654 | 304 | 555 | Upgrade
|
| Net Income Growth | 208.48% | -12.81% | 24.16% | 115.13% | -45.23% | - | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 6.30% | 20.11% | -0.01% | -0.03% | 0.07% | 2.72% | Upgrade
|
| EPS (Basic) | 114.47 | 88.75 | 122.26 | 98.52 | 46.21 | 84.68 | Upgrade
|
| EPS (Diluted) | 114.47 | 88.75 | 122.26 | 98.47 | 45.76 | 83.64 | Upgrade
|
| EPS Growth | 189.13% | -27.41% | 24.16% | 115.19% | -45.29% | - | Upgrade
|
| Free Cash Flow | - | 584 | 827 | 1,249 | -1,432 | 594 | Upgrade
|
| Free Cash Flow Per Share | - | 73.21 | 124.52 | 188.04 | -215.52 | 89.46 | Upgrade
|
| Dividend Per Share | 8.000 | 8.000 | 8.000 | 8.000 | - | - | Upgrade
|
| Gross Margin | - | 25.93% | 34.05% | 26.98% | 27.63% | 28.17% | Upgrade
|
| Operating Margin | 10.98% | 8.52% | 16.72% | 13.84% | 9.04% | 9.10% | Upgrade
|
| Profit Margin | 8.61% | 7.39% | 10.00% | 7.28% | 4.44% | 7.49% | Upgrade
|
| Free Cash Flow Margin | - | 6.10% | 10.18% | 13.90% | -20.94% | 8.02% | Upgrade
|
| EBITDA | 1,650 | 1,254 | 1,758 | 1,585 | 985 | 1,100 | Upgrade
|
| EBITDA Margin | - | 13.10% | 21.65% | 17.64% | 14.40% | 14.85% | Upgrade
|
| D&A For EBITDA | 466.5 | 438 | 400 | 341 | 367 | 426 | Upgrade
|
| EBIT | 1,183 | 816 | 1,358 | 1,244 | 618 | 674 | Upgrade
|
| EBIT Margin | - | 8.52% | 16.72% | 13.84% | 9.04% | 9.10% | Upgrade
|
| Effective Tax Rate | - | 30.64% | 35.44% | 35.70% | 32.17% | 36.13% | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.